The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases

Journal of Negative Results in BioMedicine

Volumn 16, Issue 1, 2017, Pages

  Efared, Boubacar ^a   Ebang Atsame, G ^a   Rabiou, Sani ^a   Diarra, Abdoulsalam S ^b   Tahiri, Layla ^a   Hammas, Nawal ^a,b   Smahi, Mohamed ^a,b   Amara, Bouchra ^a,b   Benjelloun, Mohamed C ^a,b   Serraj, Mounia ^a,b   Chbani, Laila ^a,b   El Fatemi, Hinde ^a,b  

^a HASSAN II UNIVERSITY HOSPITAL   (Morocco)

^b Faculty of Medicine and Pharmacy   (Morocco)

Author keywords

Bronchoalveolar lavage; Cytology; Diagnostic; Interstitial lung diseases

Indexed keywords

ADULT; ARTICLE; BRONCHIOLITIS; BRONCHOALVEOLAR LAVAGE FLUID CYTOLOGY; CELL POPULATION; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG LAVAGE; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY;

EID: 85013885059     PISSN: None     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/s12952-017-0069-0     Document Type: Article

References (22)

1. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185:1004-14.
2. Pesci A, Ricchiuti E, Ruggiero R, De Micheli A. Bronchoalveolar lavage in idiopathic pulmonary fibrosis: What does it tell us? Respir Med. 2010;104:S70-eS73.
3. Israël-Biet D, Danel C. Apport du lavage bronchoalvéolaire dans le diagnostic des pneumopathies interstitielles diffuses. Ann Pathol. 2009;29S:S98-102.
4. Wells AU. The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease. Eur Respir Rev. 2010;19:237-41.
5. Heron M, Grutters JC, ten Dam-Molenkamp KM, Hijdra D, van Heugten-Roeling A, Claessen AME, et al. Bronchoalveolar lavage cell pattern from healthy human lung. Clin Exp Immunol. 2011;167:523-31.
6. Lee W, Chung WS, Hong KS, Huh J. Clinical usefulness of bronchoalveolar lavage cellular analysis and lymphocyte subsets in diffuse interstitial lung diseases. Ann Lab Med. 2015;35:220-5.
7. Meyer KC. The clinical utility of bronchoalveolar lavage in interstitial lung disease - is it really useful? Expert Rev Respir Med. 2014;8(2):133-5.
8. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med. 2011;183:788-824.
9. Welker L, Jorres RA, Costabel U, Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J. 2004;24:1000-6.
10. Domagała-Kulawik J, Skirecki T, Maskey-Warzechowska M, Grubek-Jaworska H, Chazan R. Bronchoalveolar lavage total cell count in interstitial lung diseases-does It matter? Inflammation. 2012;35(3):803-9.
11. Nagai S, Handa T, Ito Y, Takeuchi M, Izumi T. Bronchoalveolar lavage in idiopathic interstitial lung diseases. Semin Respir Crit Care Med. 2007;28:496-503.
12. Kim DS. Diagnostic approaches to diffuse interstitial lung diseases. J Korean Med Assoc. 2009;52:5-13.
13. Wells AU. The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF) - practical implications. Respir Res. 2013;14 Suppl 1:S2.
14. Flaherty KR, King Jr TE, Raghu G, Lynch 3rd JP, Colby TV, Travis WD, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med. 2004;170:904-10.
15. Sundaram B, Gross BH, Martinez FJ, et al. Accuracy of high-resolution CT in the diagnosis of diffuse lung disease: effect of predominance and distribution of findings. AJR Am J Roentgenol. 2008;191(4):1032-9.
16. Jara-Palomares L, Martín-Juan J, Gómez-Izquierdo L, Cayuela-Domínguez A, Rodríguez-Becerra E, Rodríguez-Panadero F. Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease: prospective study of a cohort of 562 patients. Arch Bronconeumol. 2009;45(3):115-21.
17. Oda K, Ishimoto H, Yatera K, Yamada S, Nakao H, Ogoshi T, et al. Relationship between the ratios of CD4/CD8 T-lymphocytes in the bronchoalveolar lavage fluid and lymph nodes in patients with sarcoidosis. Respir Investig. 2014;52:1 7 9-8 3.
18. Tanrıverdi H, Uygur F, Örnek T, Erboy F, Altınsoy B, Atalay F, et al. Comparison of the diagnostic value of different lymphocyte subpopulations in bronchoalveolar lavage fluid in patients with biopsy proven sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2016;32(4):305-12.
19. Kowal-Bielecka O, Kowal K, Chyczewska E. Utility of bronchoalveolar lavage in evaluation of patients with connective tissue diseases. Clin Chest Med. 2010;31:423-31.
20. Petrosyan F, Culver DA, Reddy AJ. Role of bronchoalveolar lavage in the diagnosis of acute exacerbations of idiopathic pulmonary fibrosis: a retrospective study. BMC Pulm Med. 2015;15:70. doi:10.1186/s12890-015-0066-3.
21. Jo HE, Corte TJ, Moodley Y, Levin K, Westall G, Hopkins P, et al. Evaluating the interstitial lung disease multidisciplinary meeting : a survey of expert centres. BMC Pulm Med. 2016;16:22. doi:10.1186/s12890-016-0179-3.
22. Theegarten D, Müller HM, Bonella F, Wohlschlaeger J, Costabel U. Diagnostic approach to interstitial pneumonias in a single centre: report on 88 cases. Diag Pathol. 2012;7:160.